UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series

British journal of haematology, 2024-07

2024

Volltextzugriff (PDF)

Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model

Oncogene, 2015-01, Vol.34 (5), p.578-588

2015

Volltextzugriff (PDF)

NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia

Leukemia, 2015-03, Vol.29 (3), p.535-547

2015

Volltextzugriff (PDF)

The anticancer drug imatinib induces cellular autophagy

Leukemia, 2007-05, Vol.21 (5), p.936-942

2007

Volltextzugriff (PDF)

The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

Leukemia, 2013-06, Vol.27 (6), p.1416-1418

2013

Volltextzugriff (PDF)

Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model

Oncogene, 2015-01, Vol.34 (5), p.578

2015

Volltextzugriff (PDF)

Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3(+)-mediated leukemic phenotype

Leukemia, 2016-08, Vol.30 (8), p.1725-1733

2016

Volltextzugriff (PDF)

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Bone marrow transplantation (Basingstoke), 2021-04, Vol.56 (4), p.841-852

2021

Volltextzugriff (PDF)

Lenvatinib and pembrolizumab as save and effective combination treatment in 8 patients with metastasized anaplastic (ATC) or poorly differentiated thyroid carcinoma (PDTC)

Annals of oncology, 2018-10, Vol.29, p.viii646-viii646

2018

Volltextzugriff (PDF)

Pixantrone containing R‐CPOP as firstline treatment in elderly DLBCL patients with congestive heart failure or high risk of anthracycline induced cardiotoxicity

Hematological oncology, 2023-06, Vol.41 (S2), p.425-426

2023

Volltextzugriff (PDF)

A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin

Leukemia & lymphoma, 2022-07, Vol.63 (9), p.2260-2262

2022

Volltextzugriff (PDF)

Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Bone marrow transplantation (Basingstoke), 2021-08, Vol.56 (8), p.2042-2042

2021

Volltextzugriff (PDF)

Geriatric assessment scores: Predictors of prognosis and premature end of treatment in the MARTA and MARiTA study population of elderly PCNSL patients >65 years

Hematological oncology, 2023-06, Vol.41 (S2), p.407-408

2023

Volltextzugriff (PDF)

Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation

Bone marrow transplantation (Basingstoke), 2016-01, Vol.51 (1), p.127-131

2016

Volltextzugriff (PDF)

Grb10 is involved in BCR-ABL-positive leukemia in mice

Leukemia, 2015-04, Vol.29 (4), p.858-868

2015

Volltextzugriff (PDF)

Compensatory PI3-kinase Akt mTor activation regulates imatinib resistance development

Leukemia, 2005-10, Vol.19 (10), p.1774-1782

2005

Volltextzugriff (PDF)

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back

Leukemia, 2003-05, Vol.17 (5), p.829-838

2003

Volltextzugriff (PDF)

PB2126: R‐CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS WITH SIGNIFICANT REDUCED LVEF OR HIGH RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1997-1998

2022

Volltextzugriff (PDF)

F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance

Leukemia, 2015-08, Vol.29 (8), p.1763-1770

2015

Volltextzugriff (PDF)

MATRIX INDUCTION FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT OR WHOLE‐BRAIN IRRADIATION IN PRIMARY CNS LYMPHOMA. 7‐YEAR RESULTS OF THE IELSG32 RANDOMIZED TRIAL

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

NONINVASIVE DETECTION, CLASSIFICATION, AND RISK STRATIFICATION OF PRIMARY CNS LYMPHOMAS BY CTDNA PROFILING

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-γ1-driven activation of mTOR p70S6-kinase pathway

Oncogene, 2010-02, Vol.29 (5), p.739-751

2010

Volltextzugriff (PDF)

Combined androgen deprivation therapy in recurrent androgen-receptor-positive salivary duct carcinoma – a case report and review of the literature

Journal of stomatology, oral and maxillofacial surgery, 2020-11, Vol.121 (5), p.599-603

2020

Volltextzugriff (PDF)

S230: HUMAN ΒETA‐DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT‐VERSUS‐HOST DISEASE

HemaSphere, 2022-06, Vol.6, p.131-132

2022

Volltextzugriff (PDF)

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

British journal of cancer, 2005-07, Vol.93 (2), p.190-194

2005

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(213)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(105)
Humans
(79)
Animals
(61)
Oncology
(59)
Hematology
(56)
Biological And Medical Sciences
(49)
Mice
(43)
Medical Sciences
(35)
Male
(28)
Mutation
(28)
Female
(26)
Imatinib Mesylate
(26)
Benzamides
(25)
Biochemistry & Molecular Biology
(24)
Kinases
(24)
Hematologic And Hematopoietic Diseases
(23)
Phosphorylation
(22)
Business & Economics
(21)
Cell Line
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Long‐term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series

Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model

NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia

The anticancer drug imatinib induces cellular autophagy

The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model

Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3(+)-mediated leukemic phenotype

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Lenvatinib and pembrolizumab as save and effective combination treatment in 8 patients with metastasized anaplastic (ATC) or poorly differentiated thyroid carcinoma (PDTC)

Pixantrone containing R‐CPOP as firstline treatment in elderly DLBCL patients with congestive heart failure or high risk of anthracycline induced cardiotoxicity

A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin

Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Geriatric assessment scores: Predictors of prognosis and premature end of treatment in the MARTA and MARiTA study population of elderly PCNSL patients >65 years

Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation

Grb10 is involved in BCR-ABL-positive leukemia in mice

Compensatory PI3-kinase Akt mTor activation regulates imatinib resistance development

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back

PB2126: R‐CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS WITH SIGNIFICANT REDUCED LVEF OR HIGH RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY

F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance

MATRIX INDUCTION FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT OR WHOLE‐BRAIN IRRADIATION IN PRIMARY CNS LYMPHOMA. 7‐YEAR RESULTS OF THE IELSG32 RANDOMIZED TRIAL

NONINVASIVE DETECTION, CLASSIFICATION, AND RISK STRATIFICATION OF PRIMARY CNS LYMPHOMAS BY CTDNA PROFILING

Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-γ1-driven activation of mTOR p70S6-kinase pathway

Combined androgen deprivation therapy in recurrent androgen-receptor-positive salivary duct carcinoma – a case report and review of the literature

S230: HUMAN ΒETA‐DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT‐VERSUS‐HOST DISEASE

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

Suchergebnisse filtern